AIM ImmunoTech Inc.
AIM
$0.23
$0.00-0.26%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -35.58% | 18.41% | 30.03% | 11.24% | -52.18% |
| Total Depreciation and Amortization | 65.52% | -25.86% | -32.81% | -14.29% | 422.95% |
| Total Amortization of Deferred Charges | -185.94% | 185.94% | 334.78% | 281.58% | -132.49% |
| Total Other Non-Cash Items | -120.00% | 31.71% | 324.78% | 126.67% | -73.21% |
| Change in Net Operating Assets | -240.74% | -162.15% | -108.83% | -704.16% | 134.49% |
| Cash from Operations | -199.80% | -15.16% | 49.79% | -63.31% | 49.10% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -114.85% | -104.12% | -102.56% | -15.91% | -8.72% |
| Cash from Investing | -114.85% | -104.12% | -102.56% | -11.38% | -8.72% |
| Total Debt Issued | -- | -- | -- | -100.00% | 287.97% |
| Total Debt Repaid | -- | -- | 100.00% | -- | -- |
| Issuance of Common Stock | 10,411.43% | 529.85% | -- | 172,800.00% | -80.08% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 450.64% | -- | -- |
| Cash from Financing | 2,374.93% | 746.52% | 162.20% | 4,756.93% | -85.46% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,067.77% | 452.55% | -18.83% | 170.90% | -262.93% |